Motiveres du af at have styr på et komplekst landskab af flere produktionsfaciliteter? Kan du lide at være en del af et dynamisk miljø, hvor tingene går stærkt og hverdagene varierer? Hvis du samtidig motiveres af at være serviceminded, er du muligvis vores nye kollega. Du vil få en central rolle i forbindelse med bygningsvedligehold, så vi fortsat kan udvikle lægemidler, som forbedrer livskvaliteten for patienter verden over.
Jobbet
Som vores nye kollega vil du blive en afgørende medspiller i forhold til vedligehold og drift af de mest ikoniske bygninger på site Kalundborg. Dit job sikre at bygninger til enhver tid overholder gældende lovgivning samt er inspektionsparat. Du kan forvente, at dine daglige arbejdsopgaver bla. vil bestå af følgende:
Kvalifikationer
For at kvalificere dig til stillingen, forestiller vi os:
Som person forestiller vi os, at du er fleksibel med stor ansvarsfølelse, og at du har et opsøgende service mindset samt en god portion gå-på-mod. Du er en teamplayer og en god kollega, der altid er parat til at give en hånd med. Endvidere lægger vi vægt på, at du har ordenssans, og er struktureret.
Om afdelingen
Bliv en del af Novo Nordisk’s M2 Recovery i Kalundborg.
M2 Recovery består af flere grovrensningsfabrikker, vi er ca. 240 medarbejdere fordelt på forskellige teams. Dit nye team består af 22 medarbejdere, der har ansvaret for byg, kalibrering, EL samt mekanisk support
Om Novo Nordisk
I Novo Nordisk hjælper dine evner, pligtopfyldenhed og ambitioner os til at gøre en forskel for vores patienter. Til gengæld tilbyder vi dig muligheden for at arbejde med dit talent samt for faglig og personlig udvikling.
Kontakt
Vil du vide mere om stillingen, er du velkommen til at kontakte Martin Søby, Associate Manager, via telefon: 30752069 eller mrsy@novonordisk.com
Ansøgningsfrist
18. januar 2026. Vi holder løbende samtaler, og vi opfordrer dig derfor til at sende din ansøgning afsted hurtigst muligt.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic diseases and promote long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and treat, prevent, and even cure diseases that affect millions of lives. Because it takes an unordinary approach to drive real, lasting change in health.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html